Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.057 | 0.7 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.073 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |